-+ 0.00%
-+ 0.00%
-+ 0.00%

XTL BIOPHARMACEUTICALS TO ACQUIRE PSYGA BIO, ESTABLISHING A LEADING PSYCHEDELIC BIOTECHNOLOGY PLATFORM WITH ADVANCED CLINICAL PIPELINE, LICENSED GMP MANUFACTURING AND PROPRIETARY PSILOCYBIN TECHNOLOGIES

Reuters·04/29/2026 12:58:51

Please log in to view news